chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant concerning a 70 year old female with penicillin allergy who on 17-NOV-2008 was vaccinated intramuscularly with the second dose of 0.5 ml PNEUMOVAX (lot# 661577/1161X) in the left deltoid. Concomitant therapy included unspecified asthma medication, omeprazole, unspecified over the counter medications, trazodone hydrochloride, DETROL LA, citalopram, simvastatin, alendronate sodium. Medical history included hyperlipidemia, sleep apnea, osteopenia, insomnia, esophageal reflux. On 18-NOV-2008 the patient experienced extreme soreness on the left arm. On 19-NOV-2008 the left arm became red and more painful. The patient was seen in the office on 19-NOV-2008 and the patient was diagnosed with a cellulitis type reaction. The patient was treated with clindamycin 300mg 3 times a day for 7 days. Specific date of recovery of the patient is unknown. However the patient was in the office on 02-DEC-2008 and there was no mention of the reaction. The patient did receive the first dose at the age of 64 years old and it is unknown if the patient had a reaction at that time. No further information is available. This is one of several reports from the same source. Additional information has been requested. Additional information has been requested.
Fever, joint aches, muscle aches. I was paged by mom today at 1230 hrs on this weekend Saturday, d/t low grade fever and whole body aches in patient today that made him leave graduation early. Mom was asking if these symptoms were anything to worry about. I told her the low grade fever was within normal limits for yesterday's MENACTRA and Tdap boosters but the body aches were not. Update: Though bone/joint and muscle aches have been described in post-marketing reports, which I found after I got off the phone w/mom, so see below: I called mom back at 1318 hrs: she had spoken w/patient who confirmed no friends or school reports of Influenza the last 10 days of school. Therefore, I retracted my earlier advice to send him to the Immediate Care for a flu test. Instead, I recommended ALEVE three times daily today then two times daily w/meals for 2-3 more days and phone a progress report on Tues, 5/30. If symptoms resolve within 48 hrs more, I'll call it in to the VAERS as likely an adverse RX to MENACTRA since onset myalgias w/low grade fever within 24 hrs of booster.
Bad headache with severe dizziness began a little over 24 hours after my second shot.
1st dose of Shingrix in 2018/do they just need to get 2nd dose to complete the series?; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter wanted to know patient need to restart the series or do they just need to get 2nd dose to complete the series. The follow up would not be possible as no contact details were available.
Right arm had severe pain and I was unable to move or lift my arm for approximately 48 hours. Sluggishness, low grade fever, no appetite for food or drink for 72 hours
1. Vertigo, treated with Meclizine. Still occurring periodically. I have had this condition in the past but seems to be aggravated. 2. Tangy or metallic taste at back of tongue.
For the 1st 2 shots, I experienced fatigue, chills, migraine headache with aura, extreme arm pain (1st shot all the way down to my mid forearm from injection site) about 2 hours after injection. The 3rd "booster" dose, in addition to the side effects listed above, I experienced extreme fatigue, elevated heart rate (105 bpm) for about 24 hours, chest pain on left side of chest/heart, arm pit swelling/pain. I couldn't even sit up in bed.
pt recvd vax; 14 hrs later sl dec po intake;t 105 R despite having apap;examined in ofc;pt looked well w/ nl exam;
Vaccine was given 3 days early due to upcoming surgery on next appointment date. Patient was supposed to receive dose #2 of vaccine on 4/19/21; received it instead on 4/16/21.
Initially with soreness in right arm where vaccine given. By the next day, had increasing severe pain and swelling in Rt. arm, weakness in Rt. arm and hand, fever, body aches, nausea. Flu-like symptoms resolved but still with severe right arm pain radiating to shoulder and forearm, significant weakness in Rt. upper extremity (weak hand grip) now (4 days later).
Chills, severe redness and swelling, nausea. No fevers. Pt was told by nurse line to watch it. Patient came in 12/06/2011 to see provider and was given perm exemption to Pertussis containing vaccines in the future.
Arm pain  began evening of vaccine. About 48 hours after vaccine patient felt light headed and dizzy. He drank water and sat down. Then felt like he needed to lay down. About 1/2 hour later his heart rate was up and oxygen levels low. His blood pressure was also high.   He was pale and pasty looking. No fever. This lasted about 1/2 hour but he still didn?t feel right.  He felt fine about 2 hrs after the incident. Then he experienced chest pain  In the middle of the night .
This spontaneous report as received from a healthcare worker via a company representative refers to a patient of unknown age. On 05-NOV-2013 the patient was vaccinated with a dose of ZOSTAVAX, lot #, dose unspecified, expiration date of 28-SEP-2013, subcutaneous. No adverse effect reported. Additional information has been requested.
Headache, Myalgia, Arthralgia, Fever, CoughWheeze, Diarrhea, NauseaVomiting, HYPERtension,  , lypphadenopahy, stuffy nose, elevated pulse, poor sleep, Narrative: Pt experienced the following adverse reactions on the next day following the first covid vaccine: arthralgia, headache, myalgia, diarrhea, lymphadenopahy, fever nause, cough, stuffy nose, elevated BP and pulse, poor sleep. Pt self medicated with tylenol & benadryl
When the patient woke up on Friday morning (10/25/13) she found her skin near the injection site reddish but not raised. It didn't hurt or itchy but she felt hot in that area. The patch was about 2.5 inch diameter to the left of the injection site (when facing patient) about an inch apart from the site.
PATIENT RECEIVED VACCINE AND REMAINED IN STORE FOR 15 MINUTES, THEN SHE WENT TO ANOTHER STORE.   WHILE AT WALMART, SHE WAS EXPERIENCING HOT FLASHES, BLURRED VISON, STOMACH CRAMPS ACCORDING TO HER FRIEND.  THE PHARMACIST  SAID THE PATIENT WAS COMPLAINING OF TROUBLE BREATHING, DIZZINESS AND DIARRHEA.  HE CALLED EMS AND SHE WAS TRANSPORTED TO HOSPITAL.  HER FRIEND CALLED ABOUT 7:30PM THIS EVENING STATED THAT DETERMINED PATIENT HAD AN UNDERLYING UTI AND THE VACCINE EXCERBATED THE INFECTION.
Patient came to the pharmacy early Seeptember after she had seen several doctors; said she started experiencing weakness in her limbs a few hours after the vaccines were administered. She went to the ER, was hospitalized ; but is doing better. She stated that the  doctors she had visited concluded that she has developed Gullain Barre Syndrome from  the Shingles vaccine. She is still experiencing weakness, has a hard time walking
No additional AE/no PQC; Medical assistant reported VAQTA was administered after temperature excursion; This spontaneous report has been received from a medical assistant and refers to a patient of unknown age and gender.  The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported.  On 25-SEP-2023, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 dose (lot number Y3ME2 is an invalid number for hepatitis a vaccine, inactivated (VAQTA) and so the formulation could not be confirmed) administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided). The vaccine had suffered a temperature excursion prior to administration (product storage error) within timeframes of 12 hours 20 minutes and 8 hours 20 minutes at a temperature of 8.9 degree Celsius (C) and 9.4 C, respectively. No adverse events were reported for this patient.
1st dose 4 years ago, 2nd never; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose at least 4 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 27-Jan-2023 Reporter's comment: The pharmacist called due to an immunocompetent patient who never received second dose. The reporter consented to follow-up by email. Additional supportive information: Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination.
Generalized seizure which started with staring then generalized tonic-clonic X about 13 minutes. Pt was given valium in ambulance; temperature 102F.
Arthralgia, Fever & ErythemaMultiform ACETAMINOPHEN 500 MG ONCE
On June 9, I felt like the retina was detaching from the eye, no pain, it felt like the sensation of pulling a muscle, it was a growth inside the eye, I went to the doctor, and they confirmed that it was a Vitreous; but there is no treatment, I will go on July to check my eye again.
Information has been received from a consumer concerning her 12 year old daughter who on 01-JUL-2008, "yesterday", was vaccinated with the first dose of GARDASIL.  There was no concomitant medication.  On 02-JUL-2008, in the morning, the patient woke up with a fever of 102 and also had pain at the injection site.  At the time of this report, the patient's symptoms persisted.  The patient sought unspecified medical attention.  No further information is available.
itching eyes with hive around eyes and on eye lids, both hands swell and itching
Confirmed patient's name and date of birth with patient at the beginning of the call  Patient reports the following: Chief Complaint: fever and body aches and pain at injection site after vaccinations Duration: received vaccinations yesterday 10/14/20 Severity: pain is rated at 3/10 and has improved since yesterday One hour after the injections his shot started to really hurt and he felt nauseated due to the pain Less pain today and no nausea No chest pain, SOB, swelling, rash or signs of allergic reaction He has a temperature of 98 degrees F, however he feels like he has a fever with body aches. He feels like he might be getting sick, however he has no other symptoms No signs of infection. No increased redness or swelling Denies any other symptoms at this time  Protocol Used: Immunization Reactions (Adult) Protocol-Based Disposition: Home Care: patient agrees to monitor symptoms at home, take tylenol OTC and follow instructions on the box, and seek care if his symptoms worsen or fail to improve  Positive Triage Question: * Mild immunization reaction * All higher-acuity triage questions were negative  Care Advice Discussed: * Reasons To Call Back     - Fever lasts more than 3 days     - Pain lasts more than 3 days     - Injection site starts to look infected     - You become worse  Patient verbalized understanding and agrees to the POC
Approximately 5 minutes after my vaccination, I experienced the following symptoms: Migraine (lasted for 4 days). I felt such an excruciating pain with this migraine. I took Axert, Codeine, Percocet, and after 5 months an IV treatment of Magnesium Sulfate.
I started my period a week after receiving the vaccine. My period was unusually heavy for several days, with fatigue and cramping at a level higher than normal.
Developed maculopapular and vesicular rash 3 weeks after receiving varicella vaccine.
tested positive for covid-19; tested positive for covid-19; This is a spontaneous report from a contactable pharmacist via a Pfizer-sponsored program Pfizer First Connect and medical information. A 6-decade-old (reported as in her late 50's) female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration date) at unknown vaccination age via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The pharmacist reported that they had a patient who works in a long-term care facility (nursing facility reporting). The reporter stated that she has a nurse patient reporting she had first dose on an unspecified date and then tested positive for COVID-19 on an unspecified date. The reporter mentioned that the patient is scheduled to receive the second dose on 18Feb2021. The pharmacist inquired if the patient should receive the second dose on 18Feb2021 or if it should be delayed. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: The causal relationship between BNT162B2 and the events drug ineffective and Covid 19 positive cannot be excluded as the information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available.
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On unknown dates, the patients were vaccinated with improperly stored RECOMBIVAX HB (dose and route unknown) (lot# M023718 with expiration date 09-AUG-2018, lot# reported as M024261 with expiration date 30-JUL-2018) for prophylaxis. The vaccine was exposed to temperature excursion of 35 Fahrenheit degree (F) for 6 hours. There was no previous temperature excursion. No data logger was involved. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA005918: US-009507513-1701USA001893: US-009507513-1701USA001895.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Additional Details: Patient felt mild itch in throat, feeling like needing clearing of throat 5 min after shot. Felt small tightness around throat 15 min after shot. No itch, no trouble breathing or throat inflammation. Took benadryl and will continue to monitor, states may be cause of nerves also
w/in 24 hrs p/vax pt exp an inject site react @ the DTP site; on the 3rd day, react was still present; seen in office-area 1 1/2" in diameter; area was raised, warm to touch & induration present, afebrile; no tx; (5/8: needle used);
Got a Zostavax and flu shot on 10/13/09. On 10/14/09 in afternoon had quarter size red area at site of both injection site. She called on 10/15/09 to explain Zostavax site was still the size of an quarter.
Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium
At first, hot bump at site of injection. On 10/6/16, flu like symptoms.
Numbness from injection site down to fingertips/Vaccination site hypoaesthesia; Tingling from injection site down to fingertips; Sore when it comes back/ soreness is constant; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness from injection site down to fingertips/Vaccination site hypoaesthesia), VACCINATION SITE PARAESTHESIA (Tingling from injection site down to fingertips) and VACCINATION SITE PAIN (Sore when it comes back/ soreness is constant) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Dog bite (he was bitten by a dog in the right arm).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness from injection site down to fingertips/Vaccination site hypoaesthesia), VACCINATION SITE PARAESTHESIA (Tingling from injection site down to fingertips) and VACCINATION SITE PAIN (Sore when it comes back/ soreness is constant). At the time of the report, HYPOAESTHESIA (Numbness from injection site down to fingertips/Vaccination site hypoaesthesia), VACCINATION SITE PARAESTHESIA (Tingling from injection site down to fingertips) and VACCINATION SITE PAIN (Sore when it comes back/ soreness is constant) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Patient said that his numbness & tingling was from injection site down to fingertips. His soreness was constant, but the numbness & tingling are not.   No treatment details were reported.
Patient febrile with swollen, erythematous right upper extremity after receiving vaccination, diagnosed with cellulitis requiring a 10 day course of antibiotics.
Patient states that after receiving the vaccines, she did a lot of lifting.  She reports taking ibuprofen, using cool compresses and was still unable to lift the right arm at all.  There is right arm swelling.
Fever, body aches, chills, fatigue, and headache developed almost 12 hours after injection (about midnight). At 7:30am (about 19 hours post-injection), I experienced slight numbness and tingling in my hands and feet. I used the restroom and lost consciousness before I could stand up. My husband witnessed my loss of consciousness and reports that I was unconscious for 1-2 minutes. I returned to bed, rested, took a nap, and when I awoke about 1pm (almost 24 hours post-injection), all of my symptoms except fatigue had ceased.
small hives; rash on lower abdomen; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL1283), via an unspecified route of administration in the left arm on 10Jan2021 15:00 at a single dose for COVID-19 immunisation. There were no medical history. The patient was not pregnant at the time of vaccination. Concomitant medication included multivitamin. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced small hives and rash on lower abdomen on 19Jan2021 08:00. Therapeutic measures were taken as a result of the events and included treatment with topical cream. Outcome of the events was recovering. The events were considered non-serious. The patient took the second dose of bnt162b2 (lot number: ENS318) in the right arm on 29Jan2021 15:00.
Found myself kind of like nodding off, passing out; This case was reported by a consumer via interactive digital media and described the occurrence of feeling abnormal in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th May 2022, the patient received the 1st dose of Shingles vaccine. In May 2022, less than a week after receiving Shingles vaccine, the patient experienced feeling abnormal. On an unknown date, the outcome of the feeling abnormal was unknown.   It was unknown if the reporter considered the feeling abnormal to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 25-MAY-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient found himself/herself kind of like nodding off, passing out. Additional Supportive Information: The follow up would not possible, as no contact details were available.
Left upper arm with large red area 6x6x8 in. Smaller red area in middle, edges marked, warm and slight tender.
Rec Dtap and started running fever during night of 3/21/05. Parent noted pain, redness, swelling to right thigh upon awakening on 3/22/05. Seen by MD 3/22 DX cellulitis. Put on Bactrim PO.
SHORTNESS OF BREATH; PAIN IN THE LEG MUSCLE (SPECIFICALLY PAIN IN THE CALF AND BEHIND THE KNEE); This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On 13-MAR-2021, the subject experienced shortness of breath. On 13-MAR-2021, the subject experienced pain in the leg muscle (specifically pain in the calf and behind the knee). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shortness of breath on MAR-2021, and had not recovered from pain in the leg muscle (specifically pain in the calf and behind the knee). This report was non-serious.
Patient became nauseous and dizzy after immunization. Patient exhibited signs of fainting, however did not lose consciousness.
Details     Site  Arm Upper, Left   Route  --    Dose  0.5   Unit  mL    Lot Number  K72SN   Expiration Date  JUN 30, 2020    Manufacturer  GlaxoSmithKline Biologicals
never got the second Shingrix vaccine; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018, intramuscularly).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 29-APR-2022 Reporter's Comment: The patient self-reported this case. The patient received her first Shingrix vaccine but never got the second Shingrix vaccine.The patient wished to remain anonymous. The reporter did not consent to follow-up. Additional supportive information: Till the time of reporting the patient did not receive the 2nd dose of Shingrix vaccine, which led to Incomplete course of vaccination.
exactly 1 wk p/vax pt devel a fever which lasted 5 days this was w/o any sickness/cold sx; t103 ax;